Free Trial
→ ALERT: Drop these 5 stocks before the market opens tomorrow! (From Weiss Ratings) (Ad)tc pixel Free CMRAW Stock Alerts

Comera Life Sciences (CMRAW) Competitors

Compare

CMRAW vs. AIMDW, ALVOW, ARAV, ACABW, and RNA

Should you be buying Comera Life Sciences stock or one of its competitors? The main competitors of Comera Life Sciences include Ainos (AIMDW), Alvotech (ALVOW), Aravive (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), and Avidity Biosciences (RNA). These companies are all part of the "pharmaceutical products" industry.

How does Comera Life Sciences compare to Ainos?

Comera Life Sciences (NASDAQ:CMRAW) and Ainos (NASDAQ:AIMDW) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, risk, media sentiment, dividends, valuation and earnings.

In the previous week, Comera Life Sciences' average media sentiment score of 0.00 equaled Ainos'average media sentiment score.

Company Overall Sentiment
Comera Life Sciences Neutral
Ainos Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Comera Life Sciences$1.00MN/AN/AN/AN/A
Ainos$124.16KN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Comera Life SciencesN/A N/A N/A
Ainos N/A N/A N/A

Summary

Comera Life Sciences beats Ainos on 1 of the 1 factors compared between the two stocks.

How does Comera Life Sciences compare to Alvotech?

Comera Life Sciences (NASDAQ:CMRAW) and Alvotech (NASDAQ:ALVOW) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, risk, media sentiment, dividends, valuation and earnings.

Company Net Margins Return on Equity Return on Assets
Comera Life SciencesN/A N/A N/A
Alvotech N/A N/A N/A

In the previous week, Comera Life Sciences' average media sentiment score of 0.00 equaled Alvotech'saverage media sentiment score.

Company Overall Sentiment
Comera Life Sciences Neutral
Alvotech Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Comera Life Sciences$1.00MN/AN/AN/AN/A
Alvotech$586.32MN/AN/AN/AN/A

Summary

Alvotech beats Comera Life Sciences on 1 of the 1 factors compared between the two stocks.

How does Comera Life Sciences compare to Aravive?

Comera Life Sciences (NASDAQ:CMRAW) and Aravive (NASDAQ:ARAV) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, institutional ownership, risk, dividends, valuation, profitability, media sentiment and analyst recommendations.

Comera Life Sciences has higher earnings, but lower revenue than Aravive.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Comera Life Sciences$1.00MN/AN/AN/AN/A
Aravive$6.99M0.42-$66.21M-$0.90N/A

Company Net Margins Return on Equity Return on Assets
Comera Life SciencesN/A N/A N/A
Aravive N/A N/A N/A

35.8% of Aravive shares are owned by institutional investors. 60.4% of Aravive shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

In the previous week, Comera Life Sciences' average media sentiment score of 0.00 equaled Aravive'saverage media sentiment score.

Company Overall Sentiment
Comera Life Sciences Neutral
Aravive Neutral

Summary

Aravive beats Comera Life Sciences on 3 of the 3 factors compared between the two stocks.

How does Comera Life Sciences compare to Atlantic Coastal Acquisition Corp. II?

Comera Life Sciences (NASDAQ:CMRAW) and Atlantic Coastal Acquisition Corp. II (NASDAQ:ACABW) are both pharmaceutical products companies, but which is the better investment? We will compare the two companies based on the strength of their valuation, institutional ownership, profitability, earnings, media sentiment, dividends, risk and analyst recommendations.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Comera Life Sciences$1.00MN/AN/AN/AN/A
Atlantic Coastal Acquisition Corp. IIN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Comera Life SciencesN/A N/A N/A
Atlantic Coastal Acquisition Corp. II N/A N/A N/A

In the previous week, Comera Life Sciences' average media sentiment score of 0.00 equaled Atlantic Coastal Acquisition Corp. II'saverage media sentiment score.

Company Overall Sentiment
Comera Life Sciences Neutral
Atlantic Coastal Acquisition Corp. II Neutral

Summary

Comera Life Sciences beats Atlantic Coastal Acquisition Corp. II on 1 of the 1 factors compared between the two stocks.

How does Comera Life Sciences compare to Avidity Biosciences?

Comera Life Sciences (NASDAQ:CMRAW) and Avidity Biosciences (NASDAQ:RNA) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their valuation, institutional ownership, profitability, earnings, media sentiment, dividends, risk and analyst recommendations.

Avidity Biosciences has a consensus price target of $69.42, suggesting a potential upside of 437.31%. Given Avidity Biosciences' stronger consensus rating and higher possible upside, analysts plainly believe Avidity Biosciences is more favorable than Comera Life Sciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Comera Life Sciences
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Avidity Biosciences
1 Sell rating(s)
12 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.32

Comera Life Sciences has higher earnings, but lower revenue than Avidity Biosciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Comera Life Sciences$1.00MN/AN/AN/AN/A
Avidity Biosciences$18.62MN/A-$322.30MN/AN/A

Comera Life Sciences has a net margin of 0.00% compared to Avidity Biosciences' net margin of -3,650.39%. Comera Life Sciences' return on equity of 0.00% beat Avidity Biosciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Comera Life SciencesN/A N/A N/A
Avidity Biosciences -3,650.39%-44.92%-39.57%

In the previous week, Avidity Biosciences had 1 more articles in the media than Comera Life Sciences. MarketBeat recorded 1 mentions for Avidity Biosciences and 0 mentions for Comera Life Sciences. Comera Life Sciences' average media sentiment score of 0.00 equaled Avidity Biosciences'average media sentiment score.

Company Overall Sentiment
Comera Life Sciences Neutral
Avidity Biosciences Neutral

Summary

Avidity Biosciences beats Comera Life Sciences on 6 of the 9 factors compared between the two stocks.

Get Comera Life Sciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for CMRAW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CMRAW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CMRAW vs. The Competition

Export
MetricComera Life SciencesBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$443.28M$6.25B$11.87B
Dividend YieldN/A3.86%2.73%5.21%
P/E RatioN/A4.1929.0328.47
Price / SalesN/A6,879.71476.1060.92
Price / CashN/A13.1327.6236.52
Price / BookN/A77.749.676.67
Net IncomeN/A-$96.07M$3.55B$332.53M

Comera Life Sciences Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CMRAW
Comera Life Sciences
N/AN/AN/AN/A$0.00$1.00MN/A2
AIMDW
Ainos
N/A$0.08
-7.1%		N/AN/A$0.00$124.16KN/A40
ALVOW
Alvotech
N/A$0.21
-14.2%		N/AN/A$0.00$586.32MN/A4
ARAV
Aravive
N/A$0.04
flat		N/AN/A$0.00N/AN/A20
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.00
flat		N/AN/A$0.00N/AN/A15

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:CMRAW) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
Sell 99% of Your Stocks, Do THIS Instead…
Millionaire Trader Exposes: "The Single Stock Income Plan" With over 6,000 stocks on the market to choose ...
The Oxford Club | Sponsoredtc pixel
Trade this between 9:30 and 10:45 am EST
The first 75 minutes of the trading day may be the most overlooked window for consistent opportunities.If you ...
Base Camp Trading | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Elon Unveils AI Passive Income Stream for Millions of Americans
During Tesla's last earnings call, Elon Musk outlined a new AI-driven approach he says could generate $30,000-...
InvestorPlace | Sponsoredtc pixel
Invest in SpaceX Before IPO
SpaceX is already one of the most valuable private companies on Earth, and some analysts believe its valuation...
NXT Wave Research | Sponsoredtc pixel
URGENT: $2 Gold Stock With Major Discovery
A $2 gold stock is said to quietly control what may be the largest gold deposit in the world - worth nearly $1...
Paradigm Press | Sponsoredtc pixel